Jill Stefanelli
Director/Board Member at NAVIDEA BIOPHARMACEUTICALS, INC.
Net worth: 33 900 $ as of 2024-03-30
Profile
Jill Bieker Stefanelli is an Independent Director at Navidea Biopharmaceuticals, Inc. since 2023.
Previously, she was the President, Director & Chief Business Officer at Paige.
Ai, Inc. She obtained her undergraduate, graduate, and doctorate degrees from Kansas State University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-11-15 | 941,667 ( 0.94% ) | 33 900 $ | 2024-03-30 |
Jill Stefanelli active positions
| Companies | Position | Start |
|---|---|---|
| NAVIDEA BIOPHARMACEUTICALS, INC. | Director/Board Member | 2023-05-31 |
Former positions of Jill Stefanelli
| Companies | Position | End |
|---|---|---|
Paige.Ai, Inc.
 Paige.Ai, Inc. Miscellaneous Commercial ServicesCommercial Services Paige Ai, Inc. engages in revolutionizing pathology and strengthen lynchpin of medical diagnostics with quantitative, computational technology, fusing machine learning, and human expertise. It involves in building an artificial intelligence to change clinical diagnosis and treatment of cancer. The company is headquartered in New York, NY. | President | - |
Training of Jill Stefanelli
| Kansas State University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| NAVIDEA BIOPHARMACEUTICALS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Paige.Ai, Inc.
Paige.Ai, Inc. Miscellaneous Commercial ServicesCommercial Services Paige Ai, Inc. engages in revolutionizing pathology and strengthen lynchpin of medical diagnostics with quantitative, computational technology, fusing machine learning, and human expertise. It involves in building an artificial intelligence to change clinical diagnosis and treatment of cancer. The company is headquartered in New York, NY. | Commercial Services |
- Stock Market
- Insiders
- Jill Stefanelli
